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Abstract 
 
 
Objectives: To understand the key factors guiding women’s decision of 
whether or not to use breast and cervical cancer screening services (in order to 
determine how to cost effectively increase screening uptake in following conjoint). 
Methods:  We conducted eight focus groups, with Singaporean women 
aged between 40 and 64 for breast cancer screening, and between 25 and 64 years 
for cervical cancer screening, to identify the key factors that drive cancer 
screening.  Using the Health Belief Model to guide our focus group questions, we 
analyzed the responses and compared similarities and differences among 
screeners and non-screeners.   
Results:  Singaporean women understand the severity of both breast and 
cervical cancer and fear the associated lifestyle challenges that come with a cancer 
diagnosis.  With the exception of several non-screeners in the breast cancer 
group, all women reported they believed they were at risk of developing cancer.  
All women reported the benefits of early detection and accuracy of preventative 
screening.  Both screeners and non-screeners feared cancer detection during 
screening and saw the screening clinic as a place of possible cancer diagnosis.      
Conclusion:   How women perceive their cancer diagnosis, accepting the 
cancer reality or succumbing to fatalist beliefs, greatly impacts their decision to 
screen.  Screeners were more likely to report that they had recommendations from 
friends, referrals from doctors, and influences from promotion campaigns.  Non-
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screeners were more likely to have perceive fatalistic views (lack of control over a 
diagnosis (fatalism) was a unique barrier reported by non-screeners.   
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1. Background 
 
 
1.1 A Global Burden: Breast and Cervical Cancer  
 
Among women, breast and cervical cancer account for a large percent of 
worldwide deaths today.  The leading type of malignancy among women is 
breast cancer, yet cervical cancer is more common in some African nations 
(Cancer, 2014).  From 1980 to 2000, global breast cancer incidence increased at an 
annual rate of 3.1% whereas global cervical cancer incidence increased by 0.6%  
(Forouzanfar et al., 2011).  Challenges of modernization bring lifestyle changes, 
including urbanization, diet, obesity, tobacco and alcohol use, changes in 
reproductive patterns, chronic infection and increasing lifespans that all 
contribute to an ever-increasing cancer burden in Asian countries 
(Sankaranarayanan, Ramadas, & Qiao, 2014). 
Although there are few recent descriptive reports detailing the 
epidemiology of breast cancer among Southeastern Asian populations, several 
studies show the incidence of breast cancer is rising in Asian countries; breast 
cancer is the most common cancer among Asian women and is expected to 
continue to grow for the next decade (Shin et al., 2010).  Cervical cancer follows 
closely behind breast cancer and is the second most common cancer among 
Southeast Asian women.   Although cervical cancer rates are decreasing in 
Singapore, they are dropping less rapidly among Chinese than any other 
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population (Cheah, Looi, & Sivanesaratnam, 1999).  Still, South Asian women 
tend to be at lower risk for breast cancer than their white or black counterparts by 
18% and 15%, respectively (Januszewski, Tanna, & Stebbing, 2014).    
 
1.2 Singapore: Country Background  
 
An island republic with a total population of 5.31 million, Singapore has a 
diverse resident demographic that consists of Chinese (74.2%), Malays (13.3%), 
Indians (9.2%), and other ethnic groups (3.3%) (Health, 2012).  The majority of 
women are between the ages of 15-64, with a median age of residents at 37.2 years 
(Health, 2012; Statistics, 2005).  Along with Malaysia, Brunei, Indonesia, East 
Timor and the Philippines, Singapore constitutes the peninsular and island 
countries of South-East Asia.  These countries have a unique shared ethnicity, 
consisting of Chinese elements mixed with Austromalaysian influence and 
geographical contiguity that allows for useful grouping for studies of chronic 
disease prevalence as well as underlying risk factors.  The Southeast Asian 
countries share many similar health problems, in particular an increasing cancer 
rate and an underlining need to develop a coordinated approach to research and 
control to halt the spread of disease  (Moore et al., 2010). 
Singapore differs from the other Southeast Asian countries in having an 
exceptional majority of Chinese and a high level of economic development that 
exerts a major influence on lifestyle, translating into a unique demographic to 
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study cancer incidence and mortality.  As Singapore passes through the 
demographic transition, chronic non-communicable diseases will become more 
critical to address (Dans et al., 2011).  Singapore would benefit greatly by 
identifying and establishing modern cancer screening services to face an already 
increasing growing cancer burden.   
Among Asia, Singapore has the highest age-adjusted breast cancer 
incidence of any Asian nation or city, closely matching those of the West (Ng et 
al., 1998).  A study in Malaysia found low cancer survival rates because of late 
presentation are higher among individuals of non-Chinese background (Leong, 
Chuah, Kumar, & Yip, 2007), posing an interesting challenge when implementing 
country wide programs in a population as diverse as Singapore.   
 
1.3 Singapore: Breast and Cervical Cancer Prevalence  
 
Cancer is the leading cause of death in Singapore, accounting for 29.3% of 
all deaths in 2009 (Ministry of Health Singapore, 30 June 2011).  Ministry of 
Health data show that cancer made up 17.8% of all disability-adjusted life-years 
lost in 2004, with colorectal and breast cancer among the most common cancers 
locally (Phua, Chua, Ma, Heng, & Chew, 2009).  Among women, the most 
common types of cancers include breast, colorectal, lung and cervical cancers 
(Singapore, 2010).       
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Since 1968, the incidence of breast cancer in Singapore has tripled, 
becoming the most common cancer among women (Adeline Seow, 2004).  From 
1980 to 2003, breast cancer mortality rates increased from 13.9 per 100,000 
population to 14.8 per 100,000, becoming the second leading cause of cancer-
related deaths in women.  Among women aged 50–69 years old, the crude 
mortality rate for breast cancer was 47 per 100,000 compared to 16 per 100,000 in 
the 40–49 years age group in 2003 (Registry of Births and Deaths, 2004).  While 
previous studies have shown that cancer detection technology in Singapore can 
compare to the mammography services in the West, participation is still relatively 
low.  Reasons for relatively poor uptake are unknown but hypothesized to 
include high fees, poor attitudes towards breast cancer, and perceived low 
efficacy of early detection among the women  (A. Seow et al., 1997; Straughan & 
Seow, 1995). 
Cervical cancer incidence in Singapore ranks fifth among female cancers 
and is the second most common female genital tract cancer.  Although it has 
shown a slight decline at 1.4% per annum since the 1960s, the incidence is still 
relatively high at 10.6 per 100,000 women/year from 1998–2002.  Compared with 
Malay and Indian women, Chinese women seem to have a substantially higher 
risk for cervical cancer (almost 50–60%).  The incidence of cervical cancer among 
women within the 35–64 years age is 21.9 per 100,000/year (Adeline Seow, 2004).  
Previous studies suggest that women who attend pap smear screening tend to be 
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conducted in private clinics and tend be better educated, suggesting over-
screening in a select group of women and a need for more outreach to socially 
disadvantaged women with less education (Ministry of Health, 2001). 
 
1.4 Screening intervention efficacy 
 
Screening programs can aid in the early detection of several of these 
cancers and allow for successful treatment.  Which cancers are suitable candidates 
for population-level screening programs is contingent on the availability of: (i) 
diagnostic tools which can be used in routine population-level screenings; and (ii) 
effective treatment interventions.  Breast and cervical cancer both satisfy these 
criteria.  Breast cancer can be detected using mammograms and screening has 
been shown to decrease mortality in women aged 50 and over (Organization, 
2002).  Cervical cancer can be detected through the use of Papanicolaou (Pap) 
smear screening and routine screenings have been shown to reduce cancer-related 
mortality (Organization, 2005).  
The national cancer management plan for common cancers implemented 
strategies that spanned primary to tertiary services, including early disease 
detection, effective treatment, and rehabilitation (Ministry of Health, 2000).  
Singapore’s focus on breast and cervical cancer screening programs are a direct 
result of population based programs that have shown significant survival benefits 
in the screened population for these malignancies (Organization, 2002, 2005).  
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Two national-level cancer screening programs have been initiated in Singapore: 
The National Breast Screening Program, BreastScreen Singapore (BSS), launched 
in January 2002 to provide mammography services for women aged 40 and over 
(Wang, 2003); and the National Cervical Screening Program, CervicalScreen 
Singapore (CSS), launched in August 2004 to provide regular Pap smear 
screening to women aged 25-64 (Yeoh, Chew, & Wang, 2006a).  
These screenings are offered at both private general physicians and at 
polyclinics (at subsidized cost).  The goal of the BSS program is to achieve an 
enrollment target of 70% participation by women in this age group by 2008 
whereas CSS aims to achieve coverage of 80% of the targeted women attending 
for regular screening by 2010.  Mammography screening has only been recently 
introduced in Singapore in the 1990s and still has relatively low adoption rates, 
probably due to the high fees and low perceived efficacy of early detection 
among women.  Pap smear has been provided in Singapore since 1964, but only 
50% within the targeted age group of 35-64 years had undergone pap smear 
screening within the recommended triennial screening (Yeoh, Chew, & Wang, 
2006b).  Payment is in cash though, from July 2011 onwards, patients will also be 
able to use their Medisave account to pay breast cancer screenings (Ministry of 
Health Singapore, 30 June 2011). 
Although these programs have been effective at increasing the reach of 
cancer screening programs, many Singaporeans do not receive screenings 
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consistently with recommended guidelines (Ministry of Health Singapore). 
Despite the availability of information and recent increased accessibility to 
national cancer screening programs, knowledge and awareness alone are not 
sufficient enough for the adoption of preventative health screening.  The reasons 
for lower than expected uptake in these programs remain unexplained (Yeoh et 
al., 2006a).  In addition, there is a particular concern for low screening adoption 
among women who are less educated (Ministry of Health Singapore).  There are 
few studies specifically addressing the increasing burden of breast and cervical 
cancers among women and why they choose not to screen.  To our knowledge, no 
other studies have fully investigated the qualitative reasons women choose not to 
screen, especially the difference in behavior between screeners and non-screeners.   
There is a need to understand cancer screening and implement effective 
interventions for this population.  The primary aim of this study is to identify 
the key factors in the decision to undergo screening programs separately for 
breast and cervical cancers.  A secondary aim of this study is to use the results 
from this qualitative study to develop a following conjoint study to cost-
effectively increase the reach of the programs for all Singaporean women, 
including those with lower incomes and education.  Special attention will focus 
on the extent to which targeted information such as the allowance of Medisave 
funds, modest incentives, bundling screenings with other services (such as flu 
shots) can increase screening uptake.   
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Because breast cancer incident rates are not as high in South Asian 
women as their White or Black counterparts (Januszewski et al., 2014), cost-
effectiveness of mammogram services among Asians has been debated (Wong, 
Kuntz, Cowling, Lam, & Leung, 2007).  However, in women with high-risk 
characteristics, such as BRCA1/2 mutations, additional MRI screening in 
combination with regular mammograms have been shown to be cost-effective 
(Taneja et al., 2009).  Pap smear was found to be highly cost-effective in clinical 
trials and economic studies of HPV vaccines in various countries (Techakehakij 
& Feldman, 2008).  In addition, the new HPV vaccination for cervical cancer is a 
cost-effective strategy and provides a possible strategy to reduce the impact of 
HPV infection (Lee, Tay, Teoh, & Tok, 2011).  To our knowledge, there are no 
newer studies that explore rates of adoption of cancer screening services in 
comparison to other preventative medical services that may explain why 
women do not go in for cancer screening.   
The data gathered will be used to design a better national screening 
program targeting the women who are not currently screening.  Understanding 
the state of public knowledge about cancer risks and cancer screening programs 
will aid in targeting ongoing public information campaigns and make programs 
more effective.  If detected early enough, both breast and cervical cancers are 
treatable and potentially curable.  Simple and cost-effective tests are available 
which can be used to detect cancer before symptoms appear (Society, 2014).   
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1.5 Health Belief Model Conceptual Framework 
The majority of women’s knowledge of and access to breast and cervical 
cancer screening research has been conducted almost exclusively in Western 
countries (USA, UK, Australia, Canada, and Sweden) that employ organized 
cervical screenings (Markovic, Kesic, Topic, & Matejic, 2005).  The lack of a more 
holistic international view of cancer screenings suggests a need to understand 
how differences in medicine, health seeking behavior, and cultures of other 
countries affect adoption of cancer screening.  The use of theory to help construct 
and explain women’s preventative cancer screening challenges is critical to 
building upon previous findings (Rimer & Glanz, 2005).  Several theories were 
considered upon forming this study, but we eventually considered to use the 
Health Believe Model (HBM).   
 The HBM focuses on determining perceptions of the threat posed by a 
health problem (susceptibility, severity), the benefits of avoiding the threat, and 
factors influencing the decision to act (barriers, cues to action, and self-efficacy) to 
diagnose what is encouraging or discouraging people from participating.  An 
understanding of how susceptible the target population feels to the health 
problem, whether they believe it is serious, and whether they believe action can 
reduce the threat at an acceptable cost is an important first step at understanding 
the low rates of screening adoption.  Because we wanted to explore the factors 
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influencing an individual’s choice to screen, our study used the HBM to 
understand challenges to increasing cancer screening rates.  Therefore, this study 
attempts to better understand the barriers and challenges to screening behavior 
among Singapore women.  Following a Health Belief Model (HBM), we attempt 
to address women’s knowledge, beliefs, and social attitudes towards the health 
care system, physicians, and media’s influence on women’s cervical cancer 
screening practices.  
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2. Purpose of the Study 
 
 
The objective of the qualitative inquiry is to gain an in-depth 
understanding of women’s breast and cervical cancer screening behavior with a 
particular focus on:  
 Women’s perception of susceptibility and severity to breast and 
cervical cancers  
 Impact of individual knowledge regarding existence of screening 
services for these cancers  
 Perceived barriers and motivations for seeking breast and cervical 
cancer screening among screeners and non-screeners 
The qualitative data will contribute independently to our understanding 
of women’s preferences, knowledge, and potential misconceptions regarding 
breast and cervical cancer screening programs as well aid in the development of a 
future conjoint analysis survey questionnaire. 
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3. Methods 
 
 
We performed a review of the literature on the utilization of breast and 
cervical cancer screening services, with a special focus on barriers to uptake and 
strategies that have proven successful in overcoming these barriers in other 
settings. Using past studies to guide our design, we decided to conduct a series 
of focus groups in order to qualitatively uncover issues within the Singaporean 
context. The goal of the literature review and focus groups is to identify the key 
factors that guide the decision to undergo cancer screening.  Our focus group 
strategy is described below. 
 
3.1 Setting and Study Population 
 
 
We conducted focus groups (FGs) with Singaporean women aged 40 to 64 
for breast cancer screening and between 25 to 64 years for cervical cancer 
screening.  These age groups are those targeted by the National Breast and 
Cervical Screening Programs, respectively. We used purposive sampling to 
provide a range of demographic characteristics (age, marital status, and 
socioeconomic position measured through education and type of housing) and 
used a survey company to recruit matching participants from their database (See 
Table 1 and 2).  We identified screeners as those who follow Singapore Health 
Promotion Board screening guidelines.  Mammogram screeners are women who 
screened in the last year (if aged between 40 and 49) and in the last 2 years (if 
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aged 50 and above).  Pap smear screeners are women who screened in the last 3 
years.  Phone calls were made to check their eligibility and interest to participate 
in the study.  Participants were then sent a formal letter of invitation from Duke-
NUS to participate in our study. 
For each session, 10 potential participants will be invited but only up to 8 
of them will form the focus group. Excess participants will be turned away and 
still given the same incentives as those who complete the focus group session.  
Participants who completed the discussion were reimbursed with $70 
supermarket voucher each.  The FG method was chosen as it encourages 
communication between people, helping them to explore and clarify their own 
views and beliefs regarding various aspects of breast and cervical cancer 
screening (Kitzinger, 1995).  The FGs were stratified according to screeners and 
non-screeners of cancer screening services, language spoken (English or 
Mandarin), and type of program (cervical or breast cancer screening).  We hired 
two moderators, identified by the survey company, to adapt to the primary 
language of each session, one for the English session and one for the Chinese 
session.  For the Chinese session, the Chinese moderator directly transcribed into 
English.  
 
3.2 Health Belief Conceptual Framework 
 
An interview guide developed by the research team based on the Health 
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Belief Model served as the starting point for the FGs. (Gillam, 1991; Janz & 
Becker, 1984)   The Health Belief Model (HBM) is widely used in the Public Health 
field to address an individual’s choice to participate in health programs (Rimer & 
Glanz, 2005).  The HBM focuses on determining perceptions of the threat posed by 
a health problem (susceptibility, severity), the benefits of avoiding the threat, and 
factors influencing the decision to act (barriers, cues to action, and self-efficacy) to 
diagnose what is encouraging or discouraging people from participating.  An 
understanding of how susceptible the target population feels to the health 
problem, whether they believe it is serious, and whether they believe action can 
reduce the threat at an acceptable cost is an important first step at understanding 
the low rates of screening adoption. 
Because we want to explore the factors influencing an individual’s choice 
to screen, our study used the HBM to understand challenges to increasing cancer 
screening rates.  An interview guide developed by the research team based on the 
Health Belief Model served as the starting point for the focus groups.  Under this 
framework, we included open-ended questions to assess participants’ perceived 
susceptibility to breast/cervical cancer, perceived severity of breast or cervical 
cancer, perceived benefits of screening for these cancers, perceived barriers for 
undergoing screening, and perceived motivations for screening.  The focus group 
facilitator used prompts, probing questions and laddering techniques to uncover 
the participants’ personal values, ensuring that all participants had an equal 
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opportunity to contribute to the discussion.  Participants were encouraged to 
discuss and debate the questions among themselves so that ensuing discourse 
reveals participants’ thoughts and feelings.  This method of interviewing 
encourages participants to explore meaning and understanding using their own 
language and experiences, and often takes research down unexpected avenues.  
Each topic was conducted until the same themes were repeated and no new 
themes emerge.  Our broad approach to understanding and identifying the factors 
of prevention uptake allowed us to uncover themes that might have been 
overlooked in the existing literature.  
 
3.3 Demographics 
 
Participants in the breast cancer group were primarily Chinese middle 
aged women who were housewives or unemployed after obtaining their 
secondary degree education.  The majority of women in the breast cancer 
screening group were in the 50-59 age group, with a median age of the all breast 
cancer focus group participants being 53.  Highest education level achieved 
spanned from Primary to University level setting but the majority held a 
Secondary degree education.  Among occupations, the majority of individuals 
were stay at home mothers/housewives which differed from the members of the 
cervical cancer groups who were white collar technical workers (see Table 1). 
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Table 1: Summary Table, Breast Cancer Focus Groups N = 
4, total number of women = 32 
Age  Marital Status  
    40 - 49 7     Single 4 
    50 - 59 19     Married 28 
    60 + 6   
    
Education  Occupation  
    Primary or Less 5     Professional 3 
    Secondary 17     Technical-white collar worker 2 
    A Level 3     Service Industry Employee 1 
    Polytechnic 5     Self Employed/Freelancer 6 
    University 2     Part Time/Tutor/Assistant 6 
      Home Worker/Unemployed 12 
      Retired 2 
Race    
    Chinese 30   
    Indian 1   
    Pakistani 1   
 
 
Participants in the cervical cancer group were primarily Chinese middle 
aged women who work in technical-white collar occupations after obtaining their 
secondary degree education.  The majority of women in the cervical cancer 
screening group were in the 47-55 age group, with a median age of the all cervical 
cancer focus group participants being 51.  Highest education level achieved 
spanned from Primary to University level setting but the majority held a 
Secondary degree education.  Among occupations, the majority of individuals 
were employed in the white-collar technical occupations (see Table 2).   
 
Table 2: Summary Table, Cervical Cancer Focus Groups 
N = 4, total number of women = 32  
Age  Marital Status  
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    25-34 6     Single 9 
    35-46 8     Married 20 
    47-55 10     Divorced 3 
    56-65 8   
    
Education  Occupation  
    Primary or Less 2     Professional 5 
    Secondary 12     Technical-white collar worker 11 
    A Level 5     Service Industry Employee 3 
    Polytechnic 7     Part Time/Tutor/Assistant 8 
    University 6     Home Worker/Unemployed 2 
      Retired 3 
Race    
    Chinese 28   
    Malay 2   
    Indian 2   
 
 
 
3.3 Data Analysis 
 
Data collection included video and audio recording that was later 
transcribed verbatim by professional translation services provided by the survey 
company.  The interviews were digitally recorded for transcription and 
translation and then entered into Excel for coding.  In general, our data analysis 
followed standard thematic analysis involving (1) immersing oneself in the data 
and becoming familiar with the data; (2) generating initial codes; (3) searching 
for themes; (4) reviewing and refining themes; (5) defining and naming themes, 
and (6) producing a report (Braun & Clarke, 2006).   
All focus groups transcripts were first coded to highlight important 
responses.  Coding was done by two members of the research team who coded 
each session separately but met afterwards to compare results.  Using this report, 
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the research team compiled all the coded focus group transcripts to produce a 
master coding frame for both breast and cervical cancer FGs.  This master coding 
frame was updated upon completion of each transcript with new codes or 
modifications to existing codes to better fit responses.  With a list of codes from 
the master coding frame, thematic analysis was used for consolidating important 
themes that women responded to by answering the research questions.  This 
unique master coding frame was then used to identify patterns and key 
narratives underlying the discussions within each relevant cancer group.  The 
themes were identified in each transcript and then cross-checked by sharing the 
results with the entire team.  The research team discussed the final coding 
themes and reached a consensus on the emergence of themes and interpretation 
of patterns.  Discursive analysis was also used to analyze topics that may not 
have been brought up in every session due to the unique flow of each focus 
group conversation, but uncovered deep insights that helped to explain the 
variance of cancer screening behavior.  Combined, these two methods are not 
dependent on any theoretical framework but provided adequate flexibility for 
analysis.   
Similarities and differences among focus groups were compared by using 
discursive and thematic analysis, categorizing emerging patterns.  Specifically, 
we designed our study to separate screeners and non-screeners to try and 
understand underlying patterns in responses that would explain the difference in 
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screening behavior.  The results of the analysis is summarized in a table and 
possible explanations for screening differences detailed in the discussion section. 
The findings from these focus groups will then be used to design a conjoint 
analysis survey aimed at using targeted information, estimating the relative 
importance of select factors, and identifying how incentives (such as use of 
Medisave funds, advertisements, and other strategies identified via the focus 
groups) can be used to increase screening uptake. 
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4.  Results 
4.1 Breast Cancer 
 
 
Table 3:  Summary of Findings - Health Belief Model and Breast Cancer 
Topics Themes 
Perceived 
Susceptibility 
 Risk factors include diet, family history, absence of 
sexual activity, stress, radiation emitted from machines, 
and age 
 Women’s perceptions of personal breast cancer risk 
ranged from 0% to 50% irrespective of screening 
experience   
 Non-screeners reported lower personal risk than 
screeners, with many non-screeners reporting a 0% 
chance of developing cancer 
Perceived 
Cancer 
Severity 
 Perceived severity of cancer diagnosis fell into four main 
categories: increased social stigma, adapting to life with 
cancer, fears of unknown treatment, and loss of identity 
as a woman  
 Women feared removing their breasts and how cancer 
treatment can demoralize and make them feel as if they 
were “not wholesome-not a whole lady” 
 Having cancer impacts many life functions and forces the 
individual to adopt many lifestyle changes   
 Even if the cancer is treatable, women report a post-op 
fear of being a family burden, feeling like a financial 
burden, and associate cancer with a “death penalty” 
Perceived 
Mammography 
benefits 
  
 Despite general awareness of mammograms many 
individuals do not screen   
 Women reported mammograms provide accurate 
readings yet doubt they can catch cancer in early stages 
 Non-screeners reported relying upon self-checks before 
going in for a mammogram 
Perceived 
Barriers  
 Primary barriers to mammogram screening include: fear 
of cancer detection, screening pain, side effects, and 
belief that screening is “looking for trouble” 
 Some women reported possible side effects from 
radiation from technology, including mammograms 
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 Fear of cancer detection is a big barrier and women often 
choose not to go because they feel “you are looking for 
trouble”   
 Both screeners and non-screeners feared cancer detection 
during screening and saw the screening clinic as a place 
of possible cancer diagnosis    
 Fear of screening pain is a common concern among 
screeners and non-screeners, especially bad peer 
experiences that  discourage screening 
Cues to Action 
 
 Motivation for screening vary from women to women 
but there is noticeable difference between screeners and 
non-screeners 
 Screeners generally tend to have more support from 
family or friends to get screening 
 Non-screeners reported relying on self-diagnostics and 
do not get a mammogram until the diagnosis identifies 
an abnormality    
 
Topic 1: Perceived Susceptibility: Breast Cancer Knowledge/Personal Risk 
Accurate knowledge about risk factors for cervical cancer was a 
predominant theme among all focus groups.  Overall, women reported an 
understanding of factors contributing to breast cancer that include diet, family 
history, absence of sexual activity, stress, radiation emitted from machines, and 
age.  Women’s perceptions of personal breast cancer risk ranged from 0% to 50% 
irrespective of screening experience.  However, non-screeners reported lower 
personal risk than screeners, with many non-screeners believing they had a 0% 
chance of developing cancer.  One non-screener reported that “I have so many 
illness, I think there's is no space for it. (laughter) I’m diabetic, I have rheumatism, I have 
crooked feet, I'm asthmatic, I drink, I smoke, I'm just enjoying life la, if it has to have 
come it'll come. I don't think so, touchwood la, because no family history.”  (A7)  In the 
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absence of adequate knowledge about breast cancer risk factors, some women 
readily admitted their ignorance by stating “I don’t know”.  In general, women 
had high cancer awareness and believed they were personally at risk regardless 
of focus group.   
 
Topic 2: Perceived Severity: Breast Cancer Challenges 
Thematic analysis identified four primary challenges and fears women 
have when facing breast cancer: increased social stigma, adapting to life with 
cancer, fears of unknown treatment, and loss of identity as a woman.  Women 
who had not screened before reported more concern about cancer treatments and 
expressed more fears associated with unknown treatment.  “… I don't know 
like…what kind it would be? Will needles be involved? Because I'm afraid of them. Even 
when I go for an operation, will you make me go sleep first before jabbing me…” (A5) 
Both screeners and non-screeners reported fears of losing their 
womanhood and husbands as a consequence of breast cancer.  Women spoke to 
the difficulties associated with removing their breasts and how the physical side 
effects of cancer treatment demoralize and make them feel as if they were “not 
wholesome-not a whole lady”. “…Apart from losing the breast, she has to suffer from 
other side effects of the treatments. She lost her hair and her eyebrows. She felt that she 
was no longer like a woman. She felt really miserable…” (E5)  This fear of losing their 
identity was a recurring theme in other areas following cancer diagnosis.  In 
addition to losing their woman-hood, women reported fear of losing their job, 
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losing their husband, and losing their friends to cancer stigma.  Women 
elaborated on stories of colleagues who suffered great physical and mental 
challenges associated with breast cancer.     
“…My colleague had breast cancer and she shut herself up initially and she 
became very depressed. We also did not know what to say to comfort her. She was 
very lost and she didn't know people around her would view her and her 
sickness. She felt that she was such an unfortunate person. She wondered why 
she would end up in that state. So I think it is a very complicated state of 
mind…” (E7) 
 
These second-hand stories shared by friends and family who had been 
diagnosed with cancer detail the complicated physical and emotional suffering 
that participants fear.  Having cancer impacts many life functions and forces the 
individual to adopt many lifestyle changes.  “…There are many things on the mind 
of a woman who is confirmed having breast cancer. Really. Really. To her, it is like a 
death penalty unless that person is very strong. If it is someone who is not so brave, she 
won't be able to take it...” (E7)  Even if the cancer is treatable, women report a post-
op fear of being a family burden, feeling like a financial burden, and not being 
able to take anymore pressure, as if cancer was a “death penalty”. 
 
Topic 3: Mammogram Knowledge/Test Experience 
Thematic analysis identified most women had knowledge of 
mammograms.  Although all individuals are aware of mammograms, responses 
to what the procedure is like, the pain threshold, cost, how often, and where to 
get a mammogram varied.  As expected, screeners had greater knowledge than 
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non-screeners about mammogram services and were more accurate in providing 
information on actual screening procedure.  Most women reported that the 
mammogram was painful and was a barrier to screening.  Perceived costs of the 
mammogram varied from being free at public clinics to costing over 200$ after 
subsidy at private clinics.  The range of supposed screening frequency varied 
from every half year to every two years, with non-screeners reporting the latter.  
“I just heard that a mammogram is to detect the cells of the cancer, then uh, but I heard 
some say ah, mammogram sometimes they cannot detect also. then those who went for 
mammogram, still they get breast cancer. Is what i heard la…(A6)  Although both 
screeners and non-screeners believe they are personally at risk for breast cancer 
and that the mammogram was an accurate reading, women in both groups 
mentioned that mammograms cannot detect cancer if the cancer is early stage.   
 
Topic 4: Fears of Mammogram/Barriers to Cancer Screening 
Women readily discussed barriers to promoting or maintaining 
preventative screening practices.  Thematic analysis identified four primary 
barriers to getting a mammogram: fear associated with cancer detection, 
screening pain, inconvenience, and belief that screening is “looking for trouble”.  
Inconvenience included location to nearest mammogram service provider, long 
waiting queues, absence of reminder appointments, inconvenient appointments, 
and general procrastination.  Because breast cancer awareness has been an issue 
raised by the government, many individuals are aware of the risks but may find 
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it difficult to adapt their lifestyles to accommodate for screening. “I think our 
generation should be pretty aware and pretty well informed but maybe my mother’s 
generation or something, then people may not want to go. I think nowadays-“ (B5) 
Older individuals may not be as knowledgeable as the younger generation and 
their relative lack of knowledge may be an influential barrier.  
One unique side effect both screener and non-screeners reported was the 
possibility of radiation emission inducing cancer.  Increasing prevalence of 
technology and effect radiation emitted from machines all have negative effects 
on our bodies, including mammograms.  Several women reported potential 
radiation emitted from technological machines today.  One screener shared that a 
media program made her believe that even mammograms have enough 
radiation to trigger and induce breast cancer itself.  
“ I watched a Taiwan TV programme and they advocated that if there is no good 
reason, you should not go for a mammogram. They said that mammogram will 
affect the tissues/cells in your breast . You may turn from "healthy" to 
"unhealthy". Ah…” (F1)  
 
Women reported screening pain to be a significant barrier to getting a 
mammogram.  Women who have screened before report everything from slight 
physical uncomfortableness to terrible pain associated with mammograms.  
Some screeners reported that they now use self-checks rather than go in for a 
mammogram.  Non-screeners choose not to screen because of a fear of screening 
pain supported by colleague experiences who have screened.  Similarly, their 
reports associate mammography with pain, discomfort, and sometimes can lead 
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to bleeding.  Even when they are armed with the knowledge that early cancer 
detection is important and beneficial, non-screeners report the fear of pain as a 
bigger barrier.    
“I would go. Actually I felt, the whole thing is, is important to know. even 
though it is far or costs a little bit more, you know, i think its, its important. 
(laughter). the reason why i didn't go is because there are a lot of friends who 
went through, they said "eh very painful you know, very painful you know" oh 
my very painful.”(A5) 
 
 The fear of cancer detection upon screening remains one of the largest 
barriers to screening.  Both screeners and non-screeners reported fear in going to 
mammogram clinic because they associate it with risk of cancer detection.  
Although both screeners and non-screeners feared cancer detection, non-
screeners tended to report subsequent fears of unknown treatment, ineffective 
treatment, the stress associated with waiting for the test result, and a general lack 
of control over the overwhelming cancer diagnosis.   
“After my last test, the nurse told me to go back to wait for the letter or a call. 
(*laugh) They said they may call me for further examination if there is a need. 
They gave you two possibilities. I kept thinking whether I would be receiving a 
letter or a call. I was anxiously waiting for two weeks.” (E6) 
 
Many non-screeners also reported a common assumption that women 
often choose not to go because “you are looking for trouble if you go test”.  This 
belief that you will get cancer if you screen is a primary barrier and deterrent to 
screening behavior.  Even screeners empathized with their fellow non-screener 
colleague’s fears of detecting cancer upon mammogram screening.  “yah…some 
people would think in that way. Without checking, they are fine but after going for one, 
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something bad will happen to them. So they don't want to check.” (F3) The idea that 
cancer screening is similar to “asking for trouble” remained a common theme 
throughout all focus groups.  We propose that how one perceives a cancer 
diagnosis plays a vital role in determining how they choose to overcome this 
general fear of cancer detection further in our discussion.     
 
Topic 5:  Motivations for Mammogram 
Motivations and cues to screen vary from women to women.  The most 
common reported factors that motivated screening behavior were: doctor’s 
referral, peer and family influence, lower screening costs, and a detection of 
abnormal lumps.  Screeners reported more support and pressure from others to 
get screening, whereas non-screeners primarily relied on self-diagnostics and 
would not get a mammogram until the self-diagnosis identified an abnormality.   
Women who had a family history or had an awareness and knowledge of 
cancer in their family were more likely to undergo mammograms.  Women also 
mentioned the importance family, relatives, and peers played in pushing one to 
go in for a screening.  “Actually I wanted to go. But I didn’t- I was too lazy to do 
anything about it until my friend pushed me to go.” (B5)  Discussion groups focusing 
on education and raising awareness of preventative screening practices also 
served to motivate individuals to see mammograms as regular and important to 
complete.  “Yeah, but actually err also procrastinated a long time until like in a 
discussion group, then everybody has done, I’m the only- two of us, there’s two of us, so 
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they said you two better go”. (B6)  Finally, women reported a doctor’s referral, 
irrespective of public or private physician as long as they are a trusted medical 
authority figure, as primary motivations to screen. “Not exactly, because err they’re 
private. I think they… they push you to the front. I go to my gynae and she 
recommended. Yeah so…” (B3)   
Women reported detection of abnormal lumps through self-examination 
as a primary motivation for first time screenings.   Both screeners and non-
screeners rely on self-examination as a first line measure of diagnosis, however 
non-screeners solely rely on self-examination and do not use mammograms.  
“…I think for this breast hor, we can do self-examination so I am not so worried. If you 
feel any hard lumps, you should see a doctor immediately.” (E4)  Women who 
experienced finding an abnormality were much more likely to consult their 
doctor and undergo screening.  Although identifying a lump is a primary 
motivation to go for a check-up, not all individuals will adopt preventative 
screening practices.   
“It's only when we have lump.. I had a lump once, I was.. I was terrified, but 
then.. It just went la. You just pray to god then it just goes. (laughter) Ya.. You 
just pray.. (laughter) Because you, you. Like, like your family member advice 
you, eh tomorrow better go and check, then you just pray, oh god, please, then 
morning you see its gone. then YAY. (laughter) you know, but if you have a 
lump then you worry, you know, then you worry about your breast, otherwise.. 
it's public.”  (A7) 
 
Participants vary drastically in their decision to screen.  As illustrated by 
the above example, women still fear the diagnosis of cancer and may rather not 
worry about screening until abnormalities are discovered.  
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4.1 Cervical Cancer  
 
Table 4:  Summary of Findings - Health Belief Model and Cervical Cancer 
Topics Themes 
Perceived 
Susceptibility 
 All women reported knowing they are at risk 
for cervical cancer 
 Risk factors include lifestyle, diet, stress, 
smoking, family history of cervical cancer, 
number of sexual partners, and sexual 
activity 
Perceived Cervical 
Cancer Severity 
 Screeners reported greatest challenges being: 
fear of death, fear of ineffective treatment, 
fear of being a family burden, and fear of 
suffering due to treatment. 
 Non-screeners reported their greatest 
challenges were: high social stigma, loosing 
work, blaming oneself, loosing will to live 
and suicide   
 In general, there is a difference between how 
screeners and non-screeners perceive a 
cervical cancer diagnosis   
 Screeners tend to accept cancer reality but 
also focus on ways of moving forward   
 Non-Screeners struggle more with a defeated 
reality of cancer, often mentioning the denial 
and lack of control in accepting cancer reality 
Perceived Pap 
Smear Benefits 
  
 Despite general awareness of pap smears 
many individuals do not screen   
 Women have poor knowledge of pap smear 
procedures 
 Women believe pap smears provide accurate 
readings yet doubt they can catch cancer in 
early stages 
 Some women reported possible side effects 
such as scraping of the cells in the cervix and 
bleeding 
Perceived Barriers   Primary barriers to pap smear include: 
screening pain, anxiety with screening 
results, discomfort with procedure/male 
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doctor, and a belief that you will get cancer if 
you look for it  
 Both screeners and non-screeners mentioned 
that individuals avoid cancer screening 
because they would rather not know they 
have cancer 
 Women reported feeling uncomfortable with 
the sensitive nature of the procedure, the cold 
instruments, the vulnerability, and the lack of 
empathy from the doctor, irrespective of 
gender 
Cues to Action 
 
 Doctor’s advice is the primary source of 
screening motivation 
 Even if participants have a friend or family 
motivator, some participants still struggle 
with undergoing cancer screening 
 
Topic 1: Perceived Susceptibility: Cervical Cancer Knowledge/Personal Risk 
Thematic analysis identified that women’s knowledge about cervical 
cancer risk factors centered around lifestyle, diet, stress, smoking, family history, 
number of sexual partners, and sexual activity.  There was no significant 
difference in responses to cervical cancer knowledge between screeners and non-
screeners.  Different from breast cancer focus groups, all women believed they 
were personally at risk for cervical cancer, irrespective of screening experience.  
In the absence of adequate knowledge about breast cancer risk factors, some 
women readily admitted their ignorance by stating “I don’t know”.  Regardless 
of screening experience, all women reported that cancer treatment is more 
effective if caught in early stages.  
 
Topic 2: Perceived Severity: Cervical Cancer Challenges 
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Discursive analysis identified that all women perceived the severity of 
having cervical cancer, albeit none had any personal experience and only a few 
reported knowing someone facing cervical cancer.  In the absence of adequate 
knowledge, women referenced what they heard and feared from knowledge of 
other types of cancer diagnoses.  “…Maybe the pain that I will go through and I don’t 
know when I'll pass off” (D8)   Several participants mentioned the lifestyle changes 
demanded by a cancer diagnosis.   
“…it actually affects everything around you. From your family, your personal, 
your work life, your social life, everything is affected…They will see you or you 
will always carry a stigma with you when people found out that you were once a 
survivor, cancer survivor”  (C6)   
 
Screeners and non-screeners reported different challenges associated with 
having a cancer diagnosis.  Among screeners, challenges of having cancer include 
several different kinds of fears: fear of death, fear of ineffective treatment, fear of 
being a family burden, and fear of suffering due to treatment.   On the other hand, 
non-screeners reported less control over a diagnosis like cancer than their 
screener counterparts.  Non-screeners reported the greatest challenges associated 
with a cervical cancer diagnosis were: high social stigma, loosing work, blaming 
oneself, losing the will to live and suicide.   
Although both non-screeners and screeners reported social stigma 
associated with being diagnosed with cancer, only non-screeners reported 
feelings of blaming oneself and losing the will to live.  “And it feels like you did it 
you know? I don’t know why but it feels like you caused it.” (C1)  When asked what it 
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would be like to have a cancer diagnosis, one non-screener reported that “I think 
the person herself might go in denial, she might just give up, suicidal.” (C7)  There is a 
difference between how screeners and non-screeners approach acceptance of a 
cancer diagnosis.  Non-Screeners struggle more with a defeated reality of cancer, 
often mentioning the denial and lack of control in accepting cancer reality.  
Screeners tend to accept cancer reality but also focus on ways of moving forward.   
 
Topic 3: Perceived Benefits: Pap Smear Knowledge/Test Experience 
Women were aware of pap smears but readily admitted their ignorance to 
the procedure details.  Almost all participants believed the test to be accurate but 
some noted that the test fails to detect cancers at early stages.  Poor knowledge of 
pap smears was a predominant theme among all focus groups.  Non-screeners 
reported having little knowledge and shared more concerns over the procedure: 
intrusiveness, pain, or discomfort with the sensitive nature of the procedure.  
Women who did have knowledge and opted to share their statements generally 
reported positive experiences with pap smears.   
One screener, however, mentioned that the fear of pain from screening 
was a direct result of a bad experience and that she would not go for screening 
again.  “….Because I have been scared. Because the last time I did it, I was having pain. 
At the clinic, I tried to bear with it. It was also a male doctor, Then after that, I told myself 
I won't do it again. And truly, I did not do it again.” (G1) Perceived costs of the pap 
smear varied from being free at the cancer center to costing over 100$ at private 
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clinics.  The range of supposed screening frequency varied from every year to 
every three years, with non-screeners reporting the latter.  Responses to when 
women should start screening ranged from starting when sexually active to 
beginning at the age of fifty.   
 
Topic 4: Perceived Barriers: Fears of Pap Smear/Barriers to Cancer Screening 
Thematic analysis identified that fear of cancer detection was a primary 
barrier to cancer screening among all women.  Beyond the fear of cancer 
detection, women reported fears associated with pap smear itself that prevented 
screening behavior including: fear of screening pain, anxiety with screening 
results, discomfort with procedure/male doctor, and a belief that you will get 
cancer if you look for it.  Fear of screening pain was a unique concern shared 
among non-screeners who had never undergone the procedure more than 
screeners who had already had a pap smear.  One non-screener mentioned that 
listening to others share pap smear experiences made her fear screening even 
more: “Ya. But after all the sharing especially you (C6)… you said it's not only the 
entrance right, you say it's quite deep in right. More scary now” (C4)  All women, even 
those who have screened before, reported experiencing fear and anxiety 
associated with screening because of the possibility of cancer detection.     
“Actually, honestly speaking, all of us here have done it before, right? We all feel 
alright. We didn't feel any ill-effects. But there is still fear and anxiety. If not, it is 
ok. Like she said (looking at G8), we were worried about the result. During the 
test, we were wondering whether it would be very painful. laugh” (G1) 
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Women reported feeling uncomfortable with the sensitive nature of the 
procedure, the cold instruments, and the vulnerability and exposure they put 
themselves in.  Non-screeners generally report fears of pain and feeling 
uncomfortable with male doctors performing such a test.  Screeners who had 
undergone the procedure had a diverse range of opinions based on their 
experience.  Some shared similar concerns with non-screeners and shared their 
concerns of vulnerability “on the table” with male doctors who were 
“unpleasant” and made the examination uncomfortable.  Others reported they 
preferred male doctors than women doctors because women are rough and less 
empathetic.  The theme of empathy was a common desire among all women.  
Women reported wanting to receive support through this stressful and sensitive 
procedure.   
“Yes because male is more empathetic. Female, little bit you also cry or scream, 
you know that kind of thing. They not empathetic it's like all women can do it you 
can do it. Male is different they will be like, oh yes yes it's very painful, you know 
very empathetic” (D5) 
 
A recurring theme that was repeated by women in both groups was the 
“belief that you will get it [cancer] if you look for it”.  One participant said it’s the 
fear of cancer detection that prevents individuals from going.  “…'mo tai ji chui tai 
ji' (nothing better to do) (laughter) may be if you don't go for any check-up then nothing 
will happen. But if you go, some kind of problems will appear. 'Jia lat' !(it's too bad) (H4)  
Both screeners and non-screeners mentioned that individuals avoid cancer 
screening because they would rather not know they have cancer.  “...Many people 
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are scared of the result so they don't want to go for it. They rather not know about it. That 
is their thinking. Sometimes, they also fear the pain. Because not everyone can 
handle…”(G3)  In this “ignorance is bliss” perspective, women reported not 
knowing about a cancer diagnosis may allow you to live a happier and carefree 
life by ignoring the possibility of getting cancer.  “Like she said (looking at G3), you 
rather live happily without knowing it. *laugh” (G1)  The belief that “you will get it if 
you look for it” mentality is a primary barrier to undergoing cancer screening.    
Although women know that early detection is beneficial, the fears 
associated with being diagnosed with cervical cancer may be too overwhelming.  
Screeners and non-screeners differ in how they accept cancer reality that further 
impacts their screening decision.   Furthermore, the belief that you will get cancer 
if you are looking for it adds additional risk of cancer detection and prevents 
women from seeking preventative behavior, choosing to ignore and live a 
blissfully ignorant life instead.   
 
Topic 4: Cues to Action: Pap Smear Motivation 
A doctor’s order for a pap smear still remains the most influential 
motivator for cervical cancer screening.  Some women reported they would 
prefer to follow the recommendations of a trusted family doctor, but many still 
report they would follow the doctor’s advice even they didn’t have any 
relationship and trust in him/her.  “Will follow recommendation even if don't really 
trust.” (C8)  On the other hand, other women reported that they would have 
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more faith in a doctor they are friends with, and not any doctor.  “Unless it's my 
doctor friend. Because normal doctor they tell you all kinds of thing.” (C7)  Friends, 
family, and even cancer survivor stories remain important motivators for cancer 
screening.  “If someone has done it and she gives me the assurance that it's only surface 
thing ah then I will go (C4)” 
Still, even if participants have a friend or family motivator, some 
participants still struggle with undergoing cancer screening.  One participant 
urged her mother to start cervical cancer screening but still has not gone herself. 
“So for 58 years she never did it. So I dragged her to the clinic… So she believes that if you 
don’t do you wont get it ” (C1)   Despite being a motivation for her mother, 
surprisingly, this participant reports she has not yet undergone screening and is 
still scared about going. “I dare not go, I don’t know why I very scared. Everytime they 
ask me to go but I dare not go” (C1) 
The primary motivation for cervical cancer screening appear to be a 
doctor’s recommendation.  Different from breast cancer, cervical cancer is less 
common and harder to have relatives or peers that have undergone such 
experiences.  Women therefore turn to medical authority, despite some being 
skeptical of a doctor’s trustworthiness, women lack the knowledge of cervical 
cancer and are primarily motivated by a doctor’s referral to go for a pap smear.    
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5. Discussion 
 
Overall, our study adds to the existing literature on Singaporean 
women’s challenges to cancer screening and uncover important areas for future 
research.   Previous studies show that cultural and social norms may prevent the 
adoption of sensitive screening procedures, including breast and cervical cancers.  
In some Asian countries, despite understanding and believing in cancer risk, 
women did not report early detection was important because the social norms 
restricted discussing matters of sexual health and how to adopt sensitive 
practices (Andrew Smith & Biddle, 1999; Bosompra, 2001).  Straughan and Seow 
(2000) found that early detection in Singapore was not found to be important.   
Contrary to these findings, our study concludes that Singaporean women 
are aware of the benefits of early breast and cervical cancer detection, regardless 
of their screening history.  Seow and fellows (1995) found that only 58.9% of 
Singaporean women felt themselves at equal risk of getting cancer as others.  Our 
study found a wide variation of women’s perceptions of personal breast cancer 
risk, ranging from 0 to 50% irrespective of screening experience.  Non-screeners 
reported lower personal risk of developing breast cancer which might explain a 
lack of motivation to adopt preventative screening practices.  Singaporean 
women who participated in the FGs understand severity of cancer and fear the 
associated lifestyle challenges that come with a cancer diagnosis.  Despite 
reporting high screening accuracy, a large majority of eligible Singaporean 
women do not adopt screening practices and remain non-screeners.   
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Although cost of women’s screening services such as pap smear is higher 
in Asian countries compared to western countries (Ross, Nunez-Smith, Forsyth, 
& Rosenbaum, 2008), our study found that cost was not a significant reason for 
not screening.  Previous studies mention that the fee for screening prevented 
women from attending (Hewitt, Devesa, & Breen, 2004).  However, our study 
finds that while many participants mentioned cost as a barrier to screening, 
further analysis revealed that cost of screening was not the most significant 
barrier.  One non-screener admitted that she would screen, despite the cost, but 
has difficulty facing other barriers to screening such as pain and discomfort.   
“I would go. Actually I felt, the whole thing important to know. Even though it 
is far or costs a little bit more, you know, I think it’s important. (laughter) The 
reason why I didn't go is because there are a lot of friends who went through, 
they said "eh very painful you know, very painful you know" oh my very 
painful.” (A5)  
 
Inconveniences of screening in clinics, including travel and lost time, 
have been reported as barriers to cancer screening by women (Oon et al., 2011).  
Screening cost was another inconvenience but not the main barrier to adoption.  
Although most women in both focus groups would prefer reduced if not free 
cancer screening services, there are still those who reported no amount of 
subsidy would incentivize them to go.   
In a comparison between screeners and non-screeners from each cancer 
group, thematic analysis identified two unique differences that might explain 
screening behavior; how women perceive a cancer diagnosis and how much 
motivational support to go for screening were two unique differences between 
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screeners and non-screeners.  Among the breast cancer focus group, motivation 
to screen from social support was unique among screeners.  Screeners were more 
likely to report that they had recommendations from friends, referrals from 
doctors, and influences from promotion campaigns.  Within cervical cancer focus 
groups, the perceived lack of control over a diagnosis (fatalism: a belief that one 
is powerless to alter a cancer reality) was a unique barrier reported by non-
screeners.  Although screeners also shared a fear of cancer detection, they did not 
report similar fatalism but focused on ways of moving forward instead.   
  
5.1 Cancer Diagnosis: Fatalism versus Acceptance  
 
The literature on fear of cancer detection is varied and limited in the 
Singaporean context.  Previous studies on Singaporean women’s perceptions on 
mammography found that there was no relationship between attendance and a 
sense of ‘fatalism’ (a belief that one is powerless to alter a fated cancer reality) (A. 
Seow et al., 1997).  In contrast to a study of women from Great Britain, non-
screeners were significantly more likely to feel that ‘one should not go looking 
for trouble,’ and expressed a fear that you will get cancer if you screen (French et 
al., 1982).  Women reported a fear associated with knowing one had cancer and 
believed it was better to remain ignorant of cancer.  Both screeners and non-
screeners feared cancer detection during screening and saw the screening clinic 
as a place of possible cancer diagnosis.  How women perceive their cancer 
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diagnosis, accepting the cancer reality or succumbing to fatalist beliefs, greatly 
impacts their decision to screen.   
Cancer screening (both mammogram and pap smear) is a very intrusive 
and quite uncomfortable procedure.  Regardless of previous experience, 
individuals expose themselves to the sensitive nature of the test and resulting 
possibility of a life threatening diagnosis.  Both screening and non-screening 
women reported fear of cancer detection upon screening because of the belief that 
“you will get cancer if you look for it”.  Furthermore, both screeners and non-
screeners reported knowing that early detection is beneficial.  Therefore, screeners 
and non-screeners do not differ in knowledge and benefits of cancer screening, 
but are influenced by other barriers or motivations.   
Our study shows screeners and non-screeners report a difference in 
perception of a cancer diagnosis.  Cervical cancer screeners tend to accept cancer 
reality but also focus on ways of moving forward.  “Cause usually when they say 
you have cancer the first thing is denial. So have to learn to accept and say okay I have 
cancer, what is the step that you are going to do, that is how a person has to think 
forward” (D7)  Although screeners still report great fear of having cancer, they 
believe they still retain control and that cancer is not necessarily a “death 
penalty”.   Because screeners do not fixate on the cancer diagnosis, but rather 
focus on how to adapt to a life with cancer, they may be more likely to prioritize 
preventative screening behavior to identify and prevent cancer earlier instead of 
waiting until it is too late. 
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On the other hand, non-screeners struggle more with a fatalistic belief that 
one is powerless to alter a fated cancer diagnosis, often mentioning their lack of 
choice and loss of control.  “If you have it, you have no choice but to face it.”   (G5)  
Non-screeners were also more likely to report difficulties associated with a cancer 
diagnosis including high social stigma, losing work, blaming oneself, losing the 
will to live, and suicide.  “And it feels like you did it you know? I don’t know why but it 
feels like you caused it” (C1) “I think the person herself might go in denial, she might just 
give up, suicidal.” (C7) Within the breast cancer focus groups, women reported the 
fear of losing their womanhood, physical and mental suffering, and financial 
burdens contributing to a rhetoric of feeling of helplessness over an 
overwhelming cancer diagnosis.  This constructed “death penalty” perspective of 
a cancer diagnosis is a significant barrier for women and may serve to be the 
primary barrier for non-screeners.  
Fatalism and the Media 
The volume of news coverage on cancer has been found to play a role in 
promoting fatalistic beliefs about prevention because of information overload 
(Niederdeppe & Levy, 2007). Research shows that people with negative views 
about cancer are more likely to avoid cancer information, suggesting that people 
with higher levels of cancer fear and fatalism are less likely to learn about positive 
developments made in the field of cancer control (Miles, Voorwinden, Chapman, 
& Wardle, 2008).  This means that the people who would benefit most from this 
information appear to be least likely to be exposed to it, possibly providing an 
 42 
 
opportunity to attempt specific multi-component interventions.   
If fatalistic beliefs about cancer prevention are largely attributable to 
passive distribution of cancer information, particularly among individuals who 
have negative views of cancer, health educators might want to address these 
concerns using multi-component interventions (media and education) that allow 
individuals to take action instead of fixating on the fear and fatalism. This may 
shift the focus of passive fatalism from a diagnosis of cancer to active acceptance 
and positive behavior change.  One study has shown that a brief media and 
nursing intervention targeting cancer fatalism among senior citizens in the 
southern United States was successful in reducing fatalistic beliefs about cancer 
survivorship, suggesting that cancer fatalism is modifiable (Powe & Weinrich, 
1999).  Targeted education efforts could help alleviate fatalistic beliefs about 
cancer prevention. Future research should work to clarify sources of cancer 
fatalism and assess the impact of specific interventions to reduce cancer fatalism.  
Use of Multi-component Interventions 
Due to the limitations in both the scope of this study it is not possible to 
draw any strong conclusions in regards to models or programs to promote early 
detection and/or uptake of screening services or practices.  However, according to 
the limited literature available, the effectiveness of multi-component interventions 
(incorporating both media and education) have been shown to be effective at 
increasing screening, such as populations who may view cancer fatalistically.   
Multi-Component Interventions have the ability to reach otherwise 
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difficult to target populations.  The use of personal and mail invitations, and the 
delivery of face-to-face education and personal invitations hold promise for 
targeting women who have never tested before.  In a study among Asian women 
in Leicester who had never been tested before, personal home visits were most 
effective at getting women to screen  (McAvoy & Raza, 1991).  Research on 
community cancer advocates and culturally sensitive programming have showed 
high acceptability and reaching previously hard to reach immigrant Chinese 
women in Australia (Koo, Kwok, White, D'Abrew, & Roydhouse, 2012; Kwok, 
Koo, D’Abrew, White, & Roydhouse, 2011).  
Within Singapore, public relations firm Leo Burnett conducted a month-
long campaign event that combined an innovative bubble popping session (way 
for women to get rid of their excuses and go for that mammogram), media and 
press, and educational take-home materials, the Leo Burnett Singapore campaign 
reminded women of how the benefits of a mammogram outweigh the silly 
excuses given and take action to protect themselves against Breast Cancer.  
According to their results, the total number of mammogram appointments 
booked at NHDG-SingHealth Polyclinics, restructured hospitals as well as 
participating private hospitals and independent screening centers between 
October to December 2013 alone, increased to 16,500 (compared to last year’s 
registered a total of 8,430 mammograms).   
  Further studies should investigate the deeper significance with how 
women personally understand and view their cancer diagnosis.  Our study did 
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not distinguish between women’s personal beliefs versus reports of perceived 
social norms on a cancer diagnosis.  The way women come to accept cancer or feel 
enfeebled by it may help to explain the difference between screeners and non-
screeners.  Understanding this difference would allow investigators to better 
target non-screeners and implement programs to increase screening uptake. 
 
5.2 Social Support: Key Motivator   
 
Unique to the breast cancer focus groups, social support was commonly 
cited as a motivating influence to go for a mammogram among screeners.  
Screeners were more likely to report that they had recommendations from 
friends, referrals from doctors, and influences from promotion campaigns.  
Women who did not have as much support and encouragement to go for 
mammography screening were more likely to be a non-screener.  In particular, 
the motivational influence of family, friends or someone with breast cancer have 
the most significant impact on whether a woman screens or not (McCance, 
Mooney, Field, & Smith, 1995).  Previous studies suggest family member support 
is particularly important in adopting mammography (P. T. Straughan & A. Seow, 
2000) if not the most important predictor of cancer screening (A. Seow et al., 
1997).  Unlike previous findings by Straughan and Seow (2000), however, our 
study found the support of close friends and physicians were also important in 
motivating screening behavior. 
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When women were asked about their motivations to go for 
mammography, screeners reported encouragement and support from others that 
influenced their decision to undergo a mammogram.  Screeners were more likely 
to report that they had recommendations from friends, referrals from doctors, 
and influences from promotion campaigns.   
“I go to my gynae and she recommended. Yeah so…” (B3)  “Actually I wanted to 
go. But I didn’t- I was too lazy to do anything about it until my friend pushed 
me to go…” (B5)  “Yeah, but actually err also procrastinated a long time until 
like in a discussion group….there’s two of us, so they said you two better go.” 
(B6)  
 
Despite fear of going in for a mammogram, family support and 
encouragement play a significant role in preventative screening practice.  What 
seems to be most important in determining screening behavior is support, any 
kind of support: be it friend, family or professional medical advice.  
“…I dare not to go but my children always ask me, it's better to go because early 
stage can be cured. they said, you go and, if anything wrong, touchwood ah, early 
stage it can be cured rather than you don't know then at the end ah, sometime 
times if you don't die (inaudible), that's true you know but (inaudible), better 
not otherwise go through all the hassle, so we are very afraid to go.” (A8)   
 
Although we did not compare what was the most influential motivator, 
many women reported they would listen to the advice that family, friends, and 
cancer survivors gave them.  For cervical cancer, however, women seemed to be 
more likely to be influenced by medical authority and listen to a doctor’s referral.   
Previous studies show that women who lacked social support are less 
likely to screen (Allen, Sorensen, Stoddard, Colditz, & Peterson, 1998).  Women 
who did not adhere to screening guidelines or breast self-exam or mammograms 
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also admitted less social support and motivation from their network (Katapodi, 
Facione, Miaskowski, Dodd, & Waters, 2002).  Low mammography intention is 
significantly associated with lack of family and physician support (Han, 
Williams, & Harrison, 1999).  Indeed, in our study, women who did not report 
significant family or physician support as motivations to screen were more likely 
to be non-screeners.  Interestingly, however, non-screeners were as likely to 
suggest that enlisting friends to group screen would be good motivation for 
future campaigns.   
In addition to peer and family support, traditional media methods of 
empowering educational knowledge was also reported to play a role in 
encouraging screening.   
“Many people think that they won't be that "lucky". They think they won't get 
it. They don't know the importance of it. So I think campaign and education are 
very important They have to let our people know that this can happen to them 
due to our lifestyle and diet. They don't have that kind of education to know that 
this can happen to them. This is like driving. We think that accident won't 
happen to us.” (E5)  
 
Women report that education and knowledge can help be a trigger for 
others to start thinking about cancer screenings and not simply avoid the issue.  
Although most women believe they are at risk for breast cancer, they may all 
rationalize their risk differently.  Similar to how driving a car imposes risks of an 
accident, women believe they are at risk but may think the possibility is so 
unlikely that they need not worry about it.  However, unlike the car accident, 
cancer screening is a personal condition that produces unwanted lifestyle 
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challenges, unknown fears, anxiety and stress associated with a cancer diagnosis.  
Therefore, women who do not have as much support may choose to avoid 
stressing about a cancer diagnosis and choose not to screen altogether until it is 
too late.  Future studies can look into how medical professionals, friends, family, 
and media all influence the decision making process to get a screening and 
whether these are temporary or long term behavior changes to get screened. 
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5.3  Limitations 
 
The purpose of our study was to gain broad knowledge and uncover 
deep insight on how women perceive challenges to cancer screening that may 
help explain the low adoption rates in Singapore.  While our study contributes 
important findings to the current literature, there are several limitations in our 
design that could be implemented in future studies.   
Because of our small qualitative design with eight focus groups and small 
sample size, this study does not purport to be widely generalizable.  We used an 
external survey company, Qcube Pte Ltd, to select participants based on 
purposive sampling of a range of demographic characteristics (age, marital 
status, and socioeconomic position measured through education and type of 
housing). We cannot say how representative the sample is as this is a non-
probability sample.  The demographic profile of focus group participants may 
show some dissimilarity to that of the whole country, and may have over-
represented the beliefs and attitudes of a few women selected through purposive 
sampling compared to a randomly selected population of Singaporean women in 
general.   
Because we used two different moderators to separately conduct the 
Chinese and English focus groups, there was a lack of consistency among specific 
questions asked.  Moderators were told to use the focus group guide and ask 
probe questions, but allow the conversation to proceed in a semi-structured 
format.  Moderators were often inconsistent with flow of questions and in some 
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cases forget to ask certain questions that further limited our ability to compare 
the differences between screeners and non-screeners.   
Although we wanted to conduct our focus groups based on separation of 
screeners and non-screeners, women who had screened before still ended up in 
the non-screening focus groups.  These individuals were noted and their 
responses treated as if they were screeners.  However, their presence in the non-
screening focus group may have influenced and steered the conversation based 
on experience with screening.  Further studies should separate women by 
experience of screening.  Therefore, true non-screeners can be differentiated from 
women who have had screening experience and stopped or women who screen 
regularly (true screeners).  By basing a comparative study on experience with 
screening, we may be able to more easily probe for the unique barriers or 
motivating influences for preventative breast and cervical cancer screening.   
Because our focus group guides were separated by screeners and non-
screeners, it was difficult to ask certain questions pertaining to screening details.  
For example, details on screening behaviour could not be asked to non-screeners 
who had never gone for a cancer screening before.  While we asked screeners 
“What motivated you to go for your last mammogram”, we could only ask non-
screeners “Why do you think some women go for a mammogram?”  The non-parallel 
format of certain guiding questions may have produced different responses 
based on the perspective individuals were answering from.  This may have 
contributed to screeners mentioning more motivating factors to screen whereas 
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non-screeners were not prompted to personally answer what motivated them to 
screen.   
Although the Health Belief Model is a well-regarded theory and has been 
used for many studies related to breast and cervical cancer screening behavioral 
studies, women didn’t always respond to questions in first person, making it 
difficult to understand what they personally believed compared to what they 
think social norms dictate.  Studies using a Theory of Planned Behaviour 
approach to ask participants to reflect back upon how they came to their decision 
on cancer screening behaviour offer a more personalized approach to 
understanding individual barriers and motivations.   
Future studies should use parallel questioning and ask members to reflect 
upon personal motivating factors or barriers that would help a non-screener 
chose to screen.  Similarly, we did not include any questions on self-efficacy and 
an individual’s feeling of control over seeking preventative health behaviour.  
Despite our lack of questions targeting self-efficacy, women still reported a fear 
of cancer detection and associated fatalism or lack of control over their cancer 
reality.  Further research can use self-efficacy to probe the depth which with 
fatalism and other barriers related to a loss of control explain low screening 
adoption.  By specifically designing research questions that ask participants 
about their own screening behavior and confidence in performing such behavior, 
we might have been able to find more extreme differences on Singaporean 
women’s personal attitudes towards screening.    
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Conclusion 
 
Our findings contribute to the understanding of Singaporean women’s 
preferences, knowledge, and potential misconceptions of breast and cervical 
cancer screening.  While it is difficult to recommend specific health policy 
measures, our study implies several suggestions for future studies or programs 
that attempt to address screening uptake.  Singaporean women know they are 
susceptible to cancer and understand the benefits of early screening, but still 
choose not to screen, suggesting that targeted campaigns addressing the most 
important barrier to cancer screening may have more effect than general 
awareness campaigns.   
Because both screeners and non-screeners see the screening clinic as a 
place of possible cancer diagnosis and more attention should also focus on 
addressing patient fears of cancer diagnosis possibly with the use of multi-
component interventions.  Non-screeners, however, uniquely viewed a cancer 
diagnosis as a death penalty, whereas screeners chose to look at options to move 
forward.  Multicomponent-strategies to address the fatalistic belief of a cancer 
diagnosis are recommended to target non-screeners that are not being reached by 
current intervention.  On the other hand, screeners reported peer and family 
support as a key screening motivator, suggesting successful cancer screening 
programming should continue to leverage the use of peer and family support as 
motivation to screen.   
Both screeners and non-screeners reported socioeconomic barriers to 
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screening (cost, location, inconvenience, gender of doctor) and recommended 
removing such barriers for increased adoption.  Private and public health system 
officials would be advised to encourage preventative screening uptake by keeping 
them free of charge and reducing the amount of wait times for exams.  Moving 
forward, our qualitative study will help develop a conjoint survey questionnaire 
that will be used to evaluate participant willingness to pay for preventative 
screening services.  Combined, both qualitative focus group and quantitative 
conjoint studies can uncover insights that can be used to recommend and 
implement a national strategy to increase breast and cervical cancer screening 
uptake among Singaporean women. 
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APPENDIX A: FOCUS GROUP GUIDE EXAMPLE  
 
Focus group guide (Mammogram Non-Screeners) 
 
Section Topic Time 
(minutes) 
1 Introduction 5 
2 Awareness of breast cancer and available treatment 15 
3 Knowledge of mammogram 15 
4 Motivations and barriers for mammogram 25 
 BREAK 10 
5 Increasing uptake for screening programs  20 
6 Incentives for screening 15 
Total time   
 
Part 1: Introduction 
Duration Discussion 
5mins Moderator to greet and welcome participants 
Moderator self-introduction 
Purpose of focus group discussion  
- To understand what you think about mammogram screenings 
Ground rules: 
- Session will be recorded 
- Confidentiality of comments and responses 
- Everyone is encouraged to contribute 
- No right or wrong answers/opinions 
- Express any views, positive or negative as long as it is truthful 
- Opinion different from others should be voiced too even if it is 
not shared by the group 
- Be open-minded 
- Speak clearly and allow one person to speak at one time 
- Turn off mobile phones and devices 
Ice breaker 
- Name 
- Hobbies, number of kids 
 
Part 2: Awareness of breast cancer and available treatment 
Duration Discussion 
15mins Topic: What do you know about the risk of breast cancer and what 
the available treatments are? 
 
Probe question: What is the risk of getting breast cancer? 
Further questions if needed: 
- Who do you think is more likely to get breast cancer? 
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- Compared to others of the same age group, do you think you 
are more or less likely to get breast cancer? [DON’T NEED TO 
GIVE PROBABILITIES] Why? 
- Are there any health/lifestyle behaviors that could increase or 
decrease one’s risk of getting breast cancer? 
 
 
Probe question: What do you think are the most important challenges 
facing a woman who is diagnosed with breast cancer? 
Further questions if needed: 
- What are the side effects of cancer treatment like? 
- What is the cost of cancer treatment? 
- How does diagnosis of cancer impact work, social and family 
life? 
- How effective are available cancer treatments at curing 
cancer? 
- Do you think breast cancer can be treated effectively if it is 
detected early? 
 
 
 
Part 3: Knowledge of mammogram 
Duration Discussion 
15mins Topic: What do you know about mammogram? 
 
Probe question: What have you heard about mammogram and from 
where? 
Further questions if needed: 
- Under what circumstances should one start going for regular 
mammogram screening? 
- How often should one go for a mammogram? 
- How much do you think a mammogram screening costs? 
 
Probe question: What do you think are potential risks/side effects of 
mammogram? 
Further questions if needed: 
- How accurate do you think is the mammogram test?  
- Are there any ill effects of regular use of mammogram? 
 
 
Part 4: Motivations and barriers for mammogram 
Duration Discussion 
25mins Topic: What are the main motivations and barriers for mammogram? 
 
 [NON-USERS] Probe question: Why do you think some women go for a 
mammogram? 
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 [NON-USERS] Probe question: Why have you not had a mammogram 
or why did you stop going for mammogram? 
Further questions if below barriers were mentioned: 
- Difficulty in scheduling a convenient appointment for screening 
– What is a suitable appointment time (day of the week, time)? 
- Amount of time spent in the clinic – What is the longest time 
acceptable time? 
- Cost – What is the highest price you are prepared to pay? 
- [NON-USERS] Prefer not to know – go to next probe question 
 
Probe question: When you hear of cancer screening do you fear being 
told that you have cancer? 
Further questions if needed: 
- Do you fear treatment cost? 
- Do you fear becoming a burden to your family? 
- Do you fear that your quality of life would be affected? 
- Do you fear that cancer treatments might not be effective? 
[NON-USERS, IF FEAR OF KNOWING NOT MENTIONED AS BARRIER] 
Probe question: Does fear of knowing influence your decision of not 
screening? 
 
Probe question: Of all the barriers that we just discussed, which do you 
think are most important for a woman like you? 
Further questions if needed: 
- Why are these most important? 
 
 
Part 5: Increasing uptake of screening program 
Duration Discussion 
5mins Topic: Encouraging regular screening 
 
- Please write down on the piece of paper either  
1. one improvement to the current mammogram screening 
that you think would increase its attractiveness, or  
2. what they would say to a friend to convince her to take 
mammogram for the first time 
 
15mins [MODERATOR TO COLLECT PAPERS AND READ OUT PROPOSALS ONE AT 
A TIME. ASK PARTICIPANTS WHETHER THEY THINK IT WILL WORK.] 
 
Probe questions for those who think it will work: What do you like 
about this? 
 
Probe questions for those who think it will work: What do you not like 
about this? 
 
 
Part 6: Incentives for screening 
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Duration Discussion 
15mins Topic: What could be done to encourage a woman like you to go for a 
mammogram regularly? 
 
[ASSUME SCREENING COSTS ARE AS CURRENTLY CHARGED. WHEN 
DISCUSSING EACH QUESTION, INCENTIVES FROM PREVIOUS 
QUESTIONS IN THIS SECTION DO NOT CARRY OVER, UNLESS EXPLICITLY 
STATED.] 
 
Probe question: Whose advice matters the most to you when 
considering going for a mammogram?  
 Further questions if needed: 
- If the doctor recommended you to go for regular mammogram 
(as a preventive measure), would you follow his/her 
recommendation? Why? 
 
Probe question:  If you were able to get a mammogram at the same 
time with your other regular health check-ups, would you go for it? 
 
Probe question: What do you think about allowing regular screeners to 
pay lower cancer treatment costs than non-screeners? 
Further questions if needed: 
- Is this fair? Why or why not? 
 
Probe question: If mammogram were offered to you free of cost, would 
you take it? 
Further questions if needed: 
- Why or why not? 
 
Probe question: If, in addition to a mammogram being free-of-charge, 
you were also offered a cash incentive, how much would make you go 
for screening? 
Further questions if needed: 
o If cash were not available, would you accept: 
Vouchers? 
o Lower insurance premiums? 
o Medisave top-up? 
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APPENDIX B: PARTICIPANT INFORMATION SHEET AND 
FOCUS GROUP CONSENT FORM  
 
PARTICIPANT INFORMATION SHEET  
& CONSENT FORM (FOCUS GROUP) 
 
 
 
1. Project title  
Awareness of Cancer Screening Survey (ACCESS) – Focus groups 
 
2. Principal Investigator and co-investigator(s), if any, with the contact number 
and organization. 
 
 
Name Organization and Contact Number 
Principal Investigator:  
 
Dr Eric Finkelstein 
  
 
 
 
Professor 
Health Systems and Services Research, 
Duke-NUS Graduate Medical School 
eric.finkelstein@duke-nus.edu.sg; (65) 6516 2338            
                           
Co-Investigators: 
 
Dr Marcel Bilger
                                                       
 
 
 
Dr Chetna Malhotra              
 
 
 
 
Dr Gilberto de Lima 
Lopes, Jr.                                   
 
 
 
 
 
 
Dr Young Kyung Do                                                        
 
 
 
Assistant Professor  
Health Systems and Services Research, 
Duke-NUS Graduate Medical School 
marcel.bilger@duke-nus.edu.sg; (65) 6601 2330 
 
Assistant Professor  
Health Systems and Services Research, 
Duke-NUS Graduate Medical School 
chetna.malhotra@duke-nus.edu.sg; (65) 6516 5692 
 
Senior Consultant in Medical Oncology 
Assistant Director for Clinical Research,                                
Assistant Professor of Oncology                            
Department: Medical 
Oncology  
Institution: The John Hopkins Singapore 
International                        Medical Centre & John 
Hopkins University                        School of Medicine 
Assistant Professor  
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Health Systems and Services Research, 
Duke-NUS Graduate Medical School 
young.do@duke-nus.edu.sg; (65) 6516 2790 
  
 
 
3. What is the purpose of this research?  
 
You are invited to participate in a research study. This information sheet provides 
you with information about the research. The Principal Investigator (the research 
doctor or person in charge of this research) or his/her representative will also 
describe this research to you and answer all of your questions. Read the 
information below and ask questions about anything you don’t understand 
before deciding whether or not to take part. 
 
The aim of this study is to understand the key factors guiding women’s decision 
of whether or not to use cancer screening services (separately for breast and 
cervical cancer) and to determine how to cost effectively increase screening 
uptake. The focus groups will be used to identify the key factors that drive the 
decision to attend a screening exam. 
 
4. Who can participate in the research? What is the expected duration of my 
participation? What is the duration of this research? 
 
Women aged 25-64 who are citizens or permanent residents of Singapore, who 
are English-speaking or Mandarin-speaking, and who agree to be audio-taped and 
video-taped, can take part in the research.  Your involvement will be a 90-minute 
discussion.  Fieldwork will be conducted in August/September 2013.  No 
translator will be present during the focus group. 
 
5. What is the approximate number of participants involved? 
 
Up to 8 participants will be involved in each focus group discussions. We will be 
conducting 8 focus group sessions involving 64 participants in total. 
 
6. What will be done if I take part in this research? 
 
You will be asked to take part in a 90-minute. 
 
You will be expected to take part in a group discussion moderated by a 
researcher. The discussion topics may include the following: 
 
- perception of susceptibility to breast and cervical cancers 
- awareness and knowledge regarding existence of screening services for 
these cancers 
- barriers and motivations for seeking breast and cervical cancer screening 
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The focus group discussion will be audio-taped and video-taped. 
7. How will my privacy and the confidentiality of my research records be 
protected? 
 
Your identifiable information will be de-linked from data collected at the earliest 
possible stage of the research. Identifiable information will never be used in a 
publication or presentation.  
 
All research data (soft and hard copies) will be kept securely at the National 
University of Singapore (NUS) for a minimum of 10 years after research 
completion, following which the data will be destroyed. This is to allow time for 
the write-up of findings as well as a complete retrospective audit of the data, if 
necessary.  
 
8. What are the possible discomforts and risks for participants? 
No more than minimal risk is expected as a consequence of your participation.  
 
9. What is the compensation for any injury? 
Not applicable. 
 
10. Will there be reimbursement for participation? 
You will be given a $70 voucher for completing in the focus group discussion. 
 
11. What are the possible benefits to me and to others?  
The knowledge gained will benefit the public in the future by contributing to the 
provision of cancer screening in Singapore. 
 
12. Can I refuse to participate in this research? 
Participation is entirely voluntary.  You can refuse to participate or inform the study 
team that you would like to withdraw from the programme at any time without giving 
any reasons.  
13. Whom should I call if I have any questions or problems? 
Please contact Junxing Chay at 6601 1253/junxing.chay@duke-nus.edu.sg for all 
research-related matters. 
 
For an independent opinion regarding the research and the rights of research 
participants, you may contact a staff member of the National University of Singapore 
Institutional Review Board (Attn: Mr Chan Tuck Wai, at telephone 6516 1234 or email 
at irb@nus.edu.sg). 
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Consent Form 
Project title:  
Awareness of Cancer Screening Survey (ACCESS) – Focus Groups/In-depth Interviews 
 
Principal Investigator with the contact number and organization: 
Dr. Eric Finkelstein, Professor, Duke-NUS Graduate Medical School 
Tel: (65) 6516 2338 
 
I hereby acknowledge that: 
1. My signature is my acknowledgement that I have agreed to take part in the above 
research.  
2. I have received a pamphlet (or a copy of this information sheet) that explains the 
use of my data in this research. I understand its contents and agree to donate my 
data for the use of this research. 
3. I can withdraw from the research at any point of time by informing the Principal 
Investigator and all my data will be discarded. 
4. I will not have any financial benefits that result from the commercial development 
of this research. 
I agree / do not agree (PLEASE CROSS OUT) to the audio-taping and video-taping of the 
focus group discussion. 
 
_______________________________
 ___________ 
Name and Signature (Participant) Date 
 
_______________________________
 ___________ 
Name and Signature (Consent Taker) Date 
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